SEL1L expression in non-small cell lung cancer
Stefano Ferrero1, Monica Falleni, Monica Cattaneo
1Division of Pathology, Department of Medicine, Surgery and Dental Sciences, University of Milan, A.O. S. Paolo and Fondazione Ospedale Maggiore Policlinico, Mangiagalli, Regina Elena, 20142 Milan, Italy.
Human Pathology
|May 2, 2006
Summary
The SEL1L gene is expressed in early lung cancer stages and its location within cells differs by tumor type. SEL1L may indicate cell transformation in non-small cell lung carcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The SEL1L gene product is implicated in cell transformation and tumor progression across various human cancers.
- Understanding SEL1L's role in non-small cell lung carcinoma (NSCLC) is crucial for clinical insights.
Purpose of the Study:
- To investigate the clinical significance of SEL1L expression in surgically resected NSCLC.
- To correlate SEL1L expression patterns with tumor characteristics and clinical implications.
Main Methods:
- Evaluated SEL1L expression in 76 NSCLC samples using immunohistochemistry.
- Analyzed SEL1L messenger RNA and protein in lung cancer cell lines.
- Correlated SEL1L immunoreactivity with tumor histotype, grade, and subcellular location.
Main Results:
- SEL1L is minimally expressed in normal lung tissue but consistently expressed in early stages of cell transformation, including bronchial squamous metaplasia and dysplasia.
- SEL1L immunoreactivity showed distinct subcellular localization: cytoplasmic in squamous cell carcinomas and nuclear in adenocarcinomas.
- SEL1L expression was inversely correlated with tumor grade, particularly in adenocarcinomas.
Conclusions:
- SEL1L expression is an early indicator of cell transformation in NSCLC.
- The dual subcellular localization of SEL1L is linked to tumor histotype and has biological significance.
- SEL1L holds potential as a biomarker for cell transformation in non-small cell lung carcinoma.
